Ameriprise’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-992,594
| Closed | -$18.7M | – | 3816 |
|
|
2019
Q3 | $18.7M | Sell |
992,594
-415,872
| -30% | -$7.84M | 0.01% | 1189 |
|
|
2019
Q2 | $16.6M | Buy |
1,408,466
+152,676
| +12% | +$1.8M | 0.01% | 1308 |
|
|
2019
Q1 | $17.1M | Buy |
1,255,790
+115,548
| +10% | +$1.58M | 0.01% | 1259 |
|
|
2018
Q4 | $11.7M | Sell |
1,140,242
-143,515
| -11% | -$1.47M | 0.01% | 1474 |
|
|
2018
Q3 | $21.4M | Sell |
1,283,757
-464,434
| -27% | -$7.73M | 0.01% | 1246 |
|
|
2018
Q2 | $27.6M | Sell |
1,748,191
-433,401
| -20% | -$6.85M | 0.01% | 965 |
|
|
2018
Q1 | $27.7M | Buy |
2,181,592
+1,366,515
| +168% | +$17.4M | 0.01% | 953 |
|
|
2017
Q4 | $9.33M | Sell |
815,077
-42,794
| -5% | -$490K | ﹤0.01% | 1666 |
|
|
2017
Q3 | $10.5M | Buy |
857,871
+237,933
| +38% | +$2.91M | 0.01% | 1540 |
|
|
2017
Q2 | $7.1M | Buy |
619,938
+459,821
| +287% | +$5.26M | ﹤0.01% | 1817 |
|
|
2017
Q1 | $3.33M | Sell |
160,117
-43,557
| -21% | -$906K | ﹤0.01% | 2308 |
|
|
2016
Q4 | $4.24M | Buy |
203,674
+9,612
| +5% | +$200K | ﹤0.01% | 2160 |
|
|
2016
Q3 | $6.36M | Sell |
194,062
-39,572
| -17% | -$1.3M | ﹤0.01% | 1801 |
|
|
2016
Q2 | $5.83M | Buy |
233,634
+18,103
| +8% | +$452K | ﹤0.01% | 1824 |
|
|
2016
Q1 | $5.28M | Buy |
215,531
+91,388
| +74% | +$2.24M | ﹤0.01% | 1904 |
|
|
2015
Q4 | $4.1M | Buy |
124,143
+40,587
| +49% | +$1.34M | ﹤0.01% | 2173 |
|
|
2015
Q3 | $2.74M | Buy |
83,556
+49,431
| +145% | +$1.62M | ﹤0.01% | 2425 |
|
|
2015
Q2 | $1.81M | Buy |
+34,125
| New | +$1.81M | ﹤0.01% | 2805 |
|